Krishna Aluri

1.1k total citations
12 papers, 163 citations indexed

About

Krishna Aluri is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science. According to data from OpenAlex, Krishna Aluri has authored 12 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Pharmaceutical Science. Recurrent topics in Krishna Aluri's work include RNA Interference and Gene Delivery (5 papers), Molecular Biology Techniques and Applications (2 papers) and MicroRNA in disease regulation (2 papers). Krishna Aluri is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Molecular Biology Techniques and Applications (2 papers) and MicroRNA in disease regulation (2 papers). Krishna Aluri collaborates with scholars based in United States, United Kingdom and Singapore. Krishna Aluri's co-authors include Jeffrey N. Agar, Jing‐Tao Wu, Joseph P. Salisbury, Saeho Chong, Ivan Zlatev, Yuanxin Xu, Valerie A. Clausen, Diana Najarian, Chris Tran and Klaus Charissé and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Scientific Reports.

In The Last Decade

Krishna Aluri

12 papers receiving 160 citations

Peers

Krishna Aluri
Lulu Guo China
Ainslie Whiting Australia
Young Ju Yun United States
Albert S. Agustinus United States
Charlene V. Chabata United States
Lulu Guo China
Krishna Aluri
Citations per year, relative to Krishna Aluri Krishna Aluri (= 1×) peers Lulu Guo

Countries citing papers authored by Krishna Aluri

Since Specialization
Citations

This map shows the geographic impact of Krishna Aluri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Aluri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Aluri more than expected).

Fields of papers citing papers by Krishna Aluri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishna Aluri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Aluri. The network helps show where Krishna Aluri may publish in the future.

Co-authorship network of co-authors of Krishna Aluri

This figure shows the co-authorship network connecting the top 25 collaborators of Krishna Aluri. A scholar is included among the top collaborators of Krishna Aluri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishna Aluri. Krishna Aluri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Aluri, Krishna, Dhrubajyoti Datta, Nate Taneja, et al.. (2024). Single-Stranded Hairpin Loop RNAs (loopmeRNAs) Potently Induce Gene Silencing through the RNA Interference Pathway. Journal of the American Chemical Society. 1 indexed citations
2.
Aluri, Krishna, et al.. (2024). Aminobenzotriazole inhibits and induces several key drug metabolizing enzymes complicating its utility as a pan CYP inhibitor for reaction phenotyping. Clinical and Translational Science. 17(3). e13746–e13746. 3 indexed citations
3.
Proia, Theresa A., Matthew Sung, Srinivas Mamidi, et al.. (2024). Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression. CPT Pharmacometrics & Systems Pharmacology. 13(6). 994–1005. 7 indexed citations
4.
Aluri, Krishna, et al.. (2023). Pharmacokinetic evaluation of poorly soluble compounds formulated as nano- or microcrystals after intraperitoneal injection to mice. International Journal of Pharmaceutics. 636. 122787–122787. 3 indexed citations
5.
Podbevšek, Peter, Swati Gupta, Anna Bisbe, et al.. (2021). Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing. Nucleic Acids Research. 49(18). 10250–10264. 17 indexed citations
6.
Aluri, Krishna, Matthew Sullivan, Roman Manetsch, et al.. (2021). Cyclic Thiosulfinates as a Novel Class of Disulfide Cleavable Cross-Linkers for Rapid Hydrogel Synthesis. Bioconjugate Chemistry. 32(3). 584–594. 12 indexed citations
7.
Castellanos-Rizaldos, Elena, Christopher R. Brown, Joo‐Hwan Kim, et al.. (2020). RT-qPCR Methods to Support Pharmacokinetics and Drug Mechanism of Action to Advance Development of RNAi Therapeutics. Nucleic Acid Therapeutics. 30(3). 133–142. 14 indexed citations
8.
Aluri, Krishna, Joseph P. Salisbury, Jochen H.M. Prehn, & Jeffrey N. Agar. (2020). Loss of angiogenin function is related to earlier ALS onset and a paradoxical increase in ALS duration. Scientific Reports. 10(1). 3715–3715. 11 indexed citations
9.
Liu, Ju, Jing Li, Chris Tran, et al.. (2019). Oligonucleotide Quantification and Metabolite Profiling by High-Resolution and Accurate Mass Spectrometry. Bioanalysis. 11(21). 1967–1980. 30 indexed citations
10.
Ramsden, Diane, Jing‐Tao Wu, Brad Zerler, et al.. (2019). Special Section on Pharmacokinetic and Drug Metabolism Properties of Novel Therapeutic Modalities. Drug Metabolism and Disposition. 47(10). 1183–1194. 26 indexed citations
11.
Li, Jing, Chris Tran, Krishna Aluri, et al.. (2019). Discovery of a Novel Deaminated Metabolite of a Single-Stranded Oligonucleotide In Vivo by Mass Spectrometry. Bioanalysis. 11(21). 1955–1965. 17 indexed citations
12.
Donnelly, Daniel P., Joseph P. Salisbury, Krishna Aluri, et al.. (2018). Cyclic Thiosulfinates and Cyclic Disulfides Selectively Cross-Link Thiols While Avoiding Modification of Lone Thiols. Journal of the American Chemical Society. 140(24). 7377–7380. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026